[HTML][HTML] Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction …
D Lazarin-Bidóia, VC Desoti, T Ueda-Nakamura… - Free Radical Biology …, 2013 - Elsevier
Our group assays natural products that are less toxic and more effective than available
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in …
D Lazarin-Bidóia, VC Desoti… - Free Radical Biology …, 2013 - europepmc.org
Our group assays natural products that are less toxic and more effective than available
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
[PDF][PDF] Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction …
D Lazarin-Bidoia, VC Desoti… - Free Radical Biology …, 2013 - core.ac.uk
abstract Our group assays natural products that are less toxic and more effective than
available nitroheterocycles as promising therapeutic options for patients with Chagas …
available nitroheterocycles as promising therapeutic options for patients with Chagas …
Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in …
D Lazarin-Bidóia, VC Desoti, T Ueda-Nakamura… - Free Radical Biology …, 2013 - infona.pl
Our group assays natural products that are less toxic and more effective than available
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in …
D Lazarin-Bidóia, VC Desoti… - … radical biology & …, 2013 - pubmed.ncbi.nlm.nih.gov
Our group assays natural products that are less toxic and more effective than available
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
[引用][C] Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction …
D Lazarin-Bidóia, VC Desoti… - Free Radical Biology …, 2013 - cir.nii.ac.jp
Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of
reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase …
reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase …
[PDF][PDF] Further evidence of the trypanocidal action of eupomatenoid-5: Confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction …
D Lazarin-Bidoia, VC Desoti… - Free Radical Biology …, 2013 - academia.edu
abstract Our group assays natural products that are less toxic and more effective than
available nitroheterocycles as promising therapeutic options for patients with Chagas …
available nitroheterocycles as promising therapeutic options for patients with Chagas …
Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in …
D Lazarin-Bidóia, VC Desoti, T Ueda-Nakamura… - 2013 - cabidigitallibrary.org
Our group assays natural products that are less toxic and more effective than available
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …
nitroheterocycles as promising therapeutic options for patients with Chagas disease. Our …